0001144204-18-005535.txt : 20180202 0001144204-18-005535.hdr.sgml : 20180202 20180202172444 ACCESSION NUMBER: 0001144204-18-005535 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 EFFECTIVENESS DATE: 20180202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biostage, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304754 FILM NUMBER: 18571958 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 D 1 primary_doc.xml X0708 D LIVE 0001563665 Biostage, Inc. 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA MASSACHUSETTS 01746 (774) 233-7300 DELAWARE None Harvard Apparatus Regenerative Technology, Inc. Corporation true James McGorry 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer Director Thomas McNaughton 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer John Canepa 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Blaine McKee 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Thomas Robinson 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Biotechnology Decline to Disclose 06b false 2017-12-27 false true true true false 0 4244000 4244000 0 Excludes potential proceeds totaling up to $6,366,000 from the exercise of warrants. false 5 0 0 0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. false Biostage, Inc. /s/ Thomas McNaughton Thomas McNaughton Chief Financial Officer 2018-02-02